查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1498369

全球糖组学/糖生物学市场评估：依产品类型、应用、最终用户、地区、机会、预测（2017-2031）

Glycomics/Glycobiology Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 228 Pages | 商品交期: 3-5个工作天内

价格

全球糖组学/糖生物学市场规模预计将从 2023 年的 19.2 亿美元增至 2031 年的 58.5 亿美元，预计 2024 年至 2031 年的复合年增长率为 14.93%。该市场近年来呈现显着成长，预计未来将保持强劲的扩张速度。

随着研究人员不断探索聚醣的复杂性及其与其他生物分子的相互作用，异常的聚醣结构和糖基化模式在自体免疫疾病、糖尿病、癌症和其他疾病中变得越来越普遍，并且越来越多地与各种疾病有关。因此，糖组学学术领域旨在阐明聚醣的结构、功能以及对健康和疾病的影响，并为聚醣识别、管理和药物发现提供可能性。许多相互关联的变数正在推动全球糖组学市场的成长轨迹。糖组学作为诊断和治疗与异常糖基化模式相关的疾病（例如糖尿病和癌症）的潜在手段而受到广泛关注。这些尖端工具使研究人员能够进一步深入研究聚醣的复杂性及其在健康和疾病中的功能意义。

向个人化医疗的范式转变进一步强调了糖组学在确定医疗保健方向方面的重要性。透过提供针对客製化治疗计画的见解，聚醣分析有可能显着提高医疗介入的有效性和精确度。以患者为中心的医学方法表明，糖组学对于迈向以患者为中心的治疗选择有多么重要。快速发展的生物製药产业正在认识到聚醣分析对于生物药物发现的重要性。例如，2024 年 1 月 30 日，基于原位邻近连接分析的创新解决方案的领导者 Navinci Diagnostics AB Corp 与创新蛋白质组学和聚醣研究解决方案的先驱 Vector Laboratories 签署了一项协议。此次合作旨在创建一种创新的生物标记发现技术，首次识别组织样本中的蛋白质糖基化。

不断增长的医疗支出推动市场

全球医疗保健支出的稳定成长正在为全球糖组学市场带来巨大繁荣。公共和商业组织都为医学研究和开发项目提供了大量资金，这推动了糖组学等领域的投资。对聚醣在各种生物过程中的重要功能及其对人类健康影响的瞭解的加深反映在资金的增加上。人们对理解和治疗复杂疾病（其中许多涉及聚醣相关过程）的日益关注正在增加医疗保健支出。因此，对糖组学研究、诊断和治疗的需求预计在未来几年将显着增加。

全球医疗支出预计将持续增加，糖组学市场也有望大幅成长。糖组学的创新和进步预计将受到医学研发投资增加的推动。研究中心、製药公司和学术机构之间的合作有望推动这一领域的发展。这些策略联盟促进跨学科合作、资源共享和知识交流，创造有利于突破性发现和基于聚醣的疗法的创造的氛围。随着个人化医疗的形成，对聚醣研究和诊断的需求预计将迅速增加。聚醣分析在提供对疾病和治疗反应的个人化见解方面具有巨大潜力，特别强调根据每个患者独特的生物学特征定製药物治疗，考虑到这种情况的可能性很大。因此，Glycomics 有潜力为以患者为中心的医疗解决方案的开发做出重大贡献并刺激进一步成长。

本报告研究和分析了全球糖组学/糖生物学市场，提供市场规模和预测、市场动态以及主要参与者的现状和前景。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章全球糖组学/糖生物学市场展望（2017-2031 年）

  • 市场规模与预测
    • 金额
    • 数量
  • 依产品类型
    • □
    • 套件
    • 试剂、化学品
    • 碳水化合物
    • 设备
  • 依用途
    • 药物发现与开发
    • 诊断
    • 其他
  • 依最终用户
    • 学术研究所
    • 製药公司、生技公司
    • 临床实验室
    • 开发合约组织
  • 依地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东/非洲
  • 市占率：依公司划分（2023 年）

第 5 章全球糖组学/糖生物学市场展望：依地区划分（2017-2031 年）

  • 北美
    • 市场规模与预测
    • 依产品类型
    • 依用途
    • 依最终用户
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 英国
    • 俄罗斯
    • 荷兰
    • 西班牙
    • 土耳其
    • 波兰
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 澳大利亚
    • 越南
    • 韩国
    • 印尼
    • 菲律宾
  • 南美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非

第 6 章市场地图（2023 年）

  • 依产品类型
  • 依用途
  • 依最终用户
  • 依地区

第七章宏观环境与产业结构

  • 需求与供给分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

  • 生长促进因素
  • 抑製成长的因素（问题、限制因素）

第 9 章监理架构与创新

  • 临床试验
  • 专利情况
  • 监理机关的核准
  • 创新/新技术

第十章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析（2023 年）
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家市场公司）
  • 专利分析（如果适用）

第11章价格分析

第 12 章案例研究

第十三章主要公司展望

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Waters Corporation
  • New England Biolabs France SASU
  • Bruker Corporation
  • Takara Bio USA, Inc.
  • Danaher Corporation
  • Bio-Techne Corporation
  • Shimadzu Corporation

第 14 章策略建议

第十五章关于我们公司，免责声明

Product Code: MX11493

Global glycomics/glycobiology market is projected to witness a CAGR of 14.93% during the forecast period 2024-2031F, growing from USD 1.92 billion in 2023 to USD 5.85 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

Glycans' abnormal structures or glycosylation patterns are increasingly being connected to various diseases, like autoimmune disorders, diabetes, and cancer, as researchers continue to explore the intricacies of glycans and their interactions with other biomolecules. As a result, the discipline of glycomics aims to clarify glycan structures, functions, and effects on health and illness, signaling possible advances in identifying, managing, and creating new drugs. Numerous interconnected variables are driving the worldwide glycomics market's growth trajectory. Glycomomics has gained significant attention as a potential means of diagnosing and treating diseases, including diabetes and cancer, linked to aberrant glycosylation patterns. Due to these state-of-the-art tools, researchers may delve further into the complexity of glycans and their functional significance in both health and disease.

The importance of glycomics in influencing the direction of healthcare is further highlighted by the paradigm shift towards personalized medicine. Glycan profiling has the potential to significantly increase the effectiveness and accuracy of medical interventions by offering tailored insights into customized treatment plans. The patient-centered approach to healthcare emphasizes how important glycomics is to progress towards patient-centered therapeutic options. The rapidly growing biopharmaceutical sector is realizing how important glycan analysis is to creating biologics. For instance, on January 30, 2024, Navinci Diagnostics AB Corp, the leader in breakthrough in situ proximity ligation assay-based solutions, and Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, announced the signing of an agreement. The collaboration aims to create innovative biomarker discovery techniques that will identify protein glycosylation in tissue samples for the first time.

Increasing Expenditure on Healthcare to Propel the Market

The steady rise in healthcare spending across the globe is providing a significant boom to the global glycomics market. Both public and commercial organizations are contributing more money to healthcare research and development projects, which drives investments in fields such as glycomics. An improved understanding of glycans' critical function in different biological processes and their consequences for human health is reflected in increased financial commitment. More emphasis is being given to comprehending and treating complicated diseases, many of which involve glycan-related processes, resulting from boosted healthcare spending. Thus, it is anticipated that in the upcoming years, there will be a huge need for glycomics research, diagnostics, and treatments.

The worldwide healthcare expenditure is expected to continue rising, and the glycomics market is expected to rise significantly. Innovation and advances in glycomics are expected to be fueled by the increased investment in healthcare research and development. Research centers, pharmaceutical corporations, and academic institutions working together are expected to propel the sector forward. These strategic alliances promote interdisciplinary cooperation, resource sharing, and exchange of knowledge, which creates an atmosphere that is favorable for ground-breaking discoveries and creation of glycan-based therapeutics. The demand for glycomics research and diagnostics is predicted to rise sharply as personalized medicine takes shape. Glycan profiling has great potential in offering individualized insights into diseases and treatment responses, particularly considering the growing emphasis on customizing medical therapies to each patient's unique biological profile. Therefore, glycomics has the potential to significantly contribute to the development of patient-centric healthcare solutions and spur additional growth.

The pharmaceutical industry is paying more attention to the medicinal potential of glycans in addition to research and diagnostics. With tremendous potential for treating numerous diseases, the field of glycan-based therapy development is a rapidly expanding drug discovery and development area. Improved patient outcomes, addressing unmet medical needs, and collaborative initiatives between academia and industry are anticipated to accelerate the translation of glycomics research into clinically relevant medicines. Due to the rising healthcare costs, more money is being spent on research and development, and the concerted efforts of players in the government, business, and academic sectors, the worldwide glycomics market is expected to rise significantly. For instance, Thermo Fisher Scientific Inc. and TransMIT GmbH Center for Mass Spectrometric Developments announced a co-marketing agreement in June 2022 to further promote the use of mass spectrometry imaging (MSI) platforms for spatial multi-omics applications in clinical and pharmaceutical laboratories.

Expanding Biopharmaceutical Research to Expand the Market

Over the past few decades, biopharmaceutical research has rapidly evolved, with a primary focus on creating novel medicines for a range of diseases and disorders. Glycomics is one of the fields to study that has attracted a lot of interest lately. Glycans are essential to many biological functions. Growth in the global glycomics market is significant as biopharmaceutical research is growing. Biopharmaceutical research is at the forefront of medical discovery and development, especially in the areas of immunology, infectious illnesses, and oncology. Glycomics is becoming more important to researchers and pharmaceutical businesses as a means of comprehending causes of illnesses and developing personalized treatments.

Glycomics research in the biopharmaceutical industry is growing due to several variables. Advances in personalized medicine necessitate a deeper comprehension of the distinct biomarkers, such as glycans, exclusive to each patient. Glycomics can customize treatments according to a patient's unique glycan profile, increasing therapeutic efficacy and reducing adverse effects. Cancer treatment has been transformed by immunotherapies and glycomics, which is essential for comprehending the glycan-based interactions that cancer cells have with the immune system. Glycan-targeted immunotherapies are being actively investigated by researchers to enhance the efficacy of cancer treatment. Since glycans are important in many infections, they are interesting targets for vaccine development.

Glycan-based vaccines are being funded by biopharmaceutical companies to fight infectious diseases such as COVID-19, HIV, and influenza. Glycans are becoming more valuable as disease indicators. The discovery of glycan biomarkers that can help with early illness detection, disease monitoring, and therapy response assessment is being driven by biopharmaceutical research. The market for glycomics goods and services has grown significantly due to glycomics' growing significance in biopharmaceutical research. Technologies, including mass spectrometry, liquid chromatography, and glycan analysis kits, are included in the global glycomics market. It includes services such as glycoprotein characterization and glycan profiling. Innovation in glycomics research is being fostered by partnerships among research centers, pharmaceutical corporations, and university institutions. These collaborations aim to hasten the advancement of glycan-based treatments and diagnostics.

For instance, Bruker Corporation reported advances in glycoproteomics, immunopeptidomics, and other 4D proteomics workflows enabled by Collision Cross Section (CCS) on March 11, 2024. Rapid advancements in glycomics, peptidomics, and deep, at-scale proteomics research solutions from Bruker Corporation enhance its other industry-leading, high-performance life science technologies for the post-genomic era. When combined, they provide vital insights into disease biology and biomarkers for the development of next-generation molecular diagnostics and pharmaceuticals, as well as post-genomic molecular and cell biology research

Increasing Dominance of the Drug Discovery Segment

Developing novel medications is becoming more necessary as chronic disease burdens rise. Glycans are essential for biological functions such as cell-to-cell contact, making them crucial for creating new drugs. Consequently, glycan chains are changed to create medications. For instance, hyaluronan, a naturally occurring glycosaminoglycan disaccharide unit, has several medicinal uses. It is crucial for treating osteoarthritis and is used in wound care following surgery. Studying glycans at the nanoscale can help with the development of vaccinations, medication delivery strategies, and biomolecular therapies for viruses and infectious disorders. Using glycoprotein expression systems and genetic engineering methods, glycan-based self-adjuvanted vaccines can be developed to enhance immunogenicity and vaccine response. Glycobiology is, therefore, crucial to creating vaccines, which fuels the market's expansion. The Mizutani Foundation for Glycoscience received 119 proposals for research grants from 28 different countries in February 2022. Following a thorough assessment of the projects' potential, scientific and social quality, and viability, the Foundation chose to fund 14 projects with grants totaling about USD 0.51 million. Therefore, Grants and approvals are anticipated to stimulate glycobiology research and development, accelerating the segment's growth.

North America to Dominate the Glycomics/Glycobiology Market

Opportunities for North America are anticipated to increase due to the growing prevalence of chronic diseases in the United States, government funding programs, and increased research and development. Cold Spring Harbour Laboratory Press (CSHL Press), a publisher of scientific books, journals, and electronic media, launched a new initiative in September 2022 to give access to the rapidly expanding subject of glycobiology in the United States. Support for the grant for CSHL Press comes from InterVenn Biosciences, a clinical technology business using glycoproteomics to change the face of healthcare. It suggests glycobiology is receiving more attention, which is anticipated to drive market expansion in the United States in the upcoming years.

One of the developers of cutting-edge proteome and glycobiology solutions, Vector Laboratories, Inc. launched a new location in Newark, California, in March 2022. These immunofluorescence (IF) kits are fully integrated to detect glycan expression in tissue slices and allow the profiling and characterization of complex glycans in biological systems. Glycan research is becoming more popular as more academics are interested in studying glycobiology because of its possible influence on significant areas of medical research, such as oncology. Therefore, the market under study is anticipated to grow rapidly throughout the projected period due to the abovementioned factors.

Future Market Scenario (2024 - 2031F)

One of the main factors contributing to the anticipated growth of the glycomics/glycobiology market is the increasing prevalence of chronic disorders such as cancer and diabetes and the increasing popularity of personalized medicine approaches. A rising population and sedentary lifestyles are expected to propel the market growth in the forecast period. Given that technology is advancing, we can expect cutting-edge technology. Players in the market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, using unbiased lipidomics, glycomics, and metabolomics tissue imaging in conjunction with HiPLEX-IHC peptide code antibody probes from AmberGen, Bruker Corporation introduced a unique MALDI HiPLEX-IHC tissue imaging solution for timsTOF flex in April 2022.

Key Players Landscape and Outlook

Several companies are expanding their business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed products, to help researchers and to increase their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.

As part of a larger investment, by 2025, Merck KGaA will invest over USD 320.93 million (EUR 300 million) in a new Life Science Research Center at its headquarters in Darmstadt in 2023. The facility's research efforts will be concentrated on finding solutions of mRNA applications, antibody synthesis, and other biotechnological products. Establishing operations in 2027 will further strengthen Merck's commitment to scientific progress.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Glycomics/Glycobiology Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product Type
    • 4.2.1. Enzymes
      • 4.2.1.1. Glycosidases
      • 4.2.1.2. Transferases
      • 4.2.1.3. Others
    • 4.2.2. Kits
      • 4.2.2.1. Glycan Releasing Kits
      • 4.2.2.2. Glycan Labelling Kits
      • 4.2.2.3. Glycan Purification Kits
      • 4.2.2.4. Others
    • 4.2.3. Reagents and Chemicals
    • 4.2.4. Carbohydrates
      • 4.2.4.1. Oligosaccharides
      • 4.2.4.2. Monosaccharides
    • 4.2.5. Instruments
      • 4.2.5.1. Mass Spectrometry Instruments
      • 4.2.5.2. Chromatography Instruments
      • 4.2.5.3. Arrays
      • 4.2.5.4. Others
  • 4.3. By Application
    • 4.3.1. Drug Discovery and Development
    • 4.3.2. Diagnostics
    • 4.3.3. Others
  • 4.4. By End-user
    • 4.4.1. Academic and Research Institutes
    • 4.4.2. Pharmaceutical and Biotechnology Companies
    • 4.4.3. Clinical Laboratories
    • 4.4.4. Contract Research Organisations
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Glycomics/Glycobiology Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product Type
      • 5.1.2.1. Enzymes
        • 5.1.2.1.1. Glycosidases
        • 5.1.2.1.2. Transferases
        • 5.1.2.1.3. Others
      • 5.1.2.2. Kits
        • 5.1.2.2.1. Glycan Releasing Kits
        • 5.1.2.2.2. Glycan Labelling Kits
        • 5.1.2.2.3. Glycan Purification Kits
        • 5.1.2.2.4. Others
      • 5.1.2.3. Reagents and Chemicals
      • 5.1.2.4. Carbohydrates
        • 5.1.2.4.1. Oligosaccharides
        • 5.1.2.4.2. Monosaccharides
      • 5.1.2.5. Instruments
        • 5.1.2.5.1. Mass Spectrometry Instruments
        • 5.1.2.5.2. Chromatography Instruments
        • 5.1.2.5.3. Arrays
        • 5.1.2.5.4. Others
    • 5.1.3. By Application
      • 5.1.3.1. Drug Discovery and Development
      • 5.1.3.2. Diagnostics
      • 5.1.3.3. Others
    • 5.1.4. By End-user
      • 5.1.4.1. Academic and Research Institutes
      • 5.1.4.2. Pharmaceutical and Biotechnology Companies
      • 5.1.4.3. Clinical Laboratories
      • 5.1.4.4. Contract Research Organisations
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
        • 5.1.5.1.1. By Value
        • 5.1.5.1.2. By Volume
      • 5.1.5.2. By Product Type
        • 5.1.5.2.1. Enzymes
          • 5.1.5.2.1.1. Glycosidases
          • 5.1.5.2.1.2. Transferases
          • 5.1.5.2.1.3. Others
        • 5.1.5.2.2. Kits
          • 5.1.5.2.2.1. Glycan Releasing Kits
          • 5.1.5.2.2.2. Glycan Labelling Kits
          • 5.1.5.2.2.3. Glycan Purification Kits
          • 5.1.5.2.2.4. Others
        • 5.1.5.2.3. Reagents and Chemicals
        • 5.1.5.2.4. Carbohydrates
          • 5.1.5.2.4.1. Oligosaccharides
          • 5.1.5.2.4.2. Monosaccharides
        • 5.1.5.2.5. Instruments
          • 5.1.5.2.5.1. Mass Spectrometry Instruments
          • 5.1.5.2.5.2. Chromatography Instruments
          • 5.1.5.2.5.3. Arrays
          • 5.1.5.2.5.4. Others
      • 5.1.5.3. By Application
        • 5.1.5.3.1. Drug Discovery and Development
        • 5.1.5.3.2. Diagnostics
        • 5.1.5.3.3. Others
      • 5.1.5.4. By End-user
        • 5.1.5.4.1. Academic and Research Institutes
        • 5.1.5.4.2. Pharmaceutical and Biotechnology Companies
        • 5.1.5.4.3. Clinical Laboratories
        • 5.1.5.4.4. Contract Research Organisations
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product Type
  • 6.2. By Application
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Thermo Fisher Scientific Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Merck KGaA
  • 13.3. Agilent Technologies, Inc.
  • 13.4. Waters Corporation
  • 13.5. New England Biolabs France SASU
  • 13.6. Bruker Corporation
  • 13.7. Takara Bio USA, Inc.
  • 13.8. Danaher Corporation
  • 13.9. Bio-Techne Corporation
  • 13.10. Shimadzu Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 3. Global Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 4. Global Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Glycomics/Glycobiology Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 9. North America Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 10. North America Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Glycomics/Glycobiology Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 15. United States Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 16. United States Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 20. Canada Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 21. Canada Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 25. Mexico Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 26. Mexico Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 30. Europe Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 31. Europe Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Glycomics/Glycobiology Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 36. Germany Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 37. Germany Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 41. France Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 42. France Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 43. France Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 46. Italy Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 47. Italy Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 51. United Kingdom Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 52. United Kingdom Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 56. Russia Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 57. Russia Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 61. Netherlands Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 62. Netherlands Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 66. Spain Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 67. Spain Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 71. Turkey Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 72. Turkey Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 76. Poland Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 77. Poland Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 81. South America Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 82. South America Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Glycomics/Glycobiology Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 87. Brazil Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 88. Brazil Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 92. Argentina Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 93. Argentina Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 97. Asia-Pacific Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 98. Asia-Pacific Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Glycomics/Glycobiology Market Share (%), By Country, 2017-2031F
  • Figure 101. India Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 103. India Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 104. India Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 105. India Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 108. China Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 109. China Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 110. China Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 113. Japan Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 114. Japan Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 118. Australia Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 119. Australia Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 123. Vietnam Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 124. Vietnam Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 128. South Korea Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 129. South Korea Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 133. Indonesia Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 134. Indonesia Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 138. Philippines Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 139. Philippines Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 143. Middle East & Africa Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 144. Middle East & Africa Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Glycomics/Glycobiology Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 149. Saudi Arabia Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 150. Saudi Arabia Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 154. UAE Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 155. UAE Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Glycomics/Glycobiology Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Glycomics/Glycobiology Market, By Volume, in Million Units, 2017-2031F
  • Figure 159. South Africa Glycomics/Glycobiology Market Share (%), By Product Type, 2017-2031F
  • Figure 160. South Africa Glycomics/Glycobiology Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Glycomics/Glycobiology Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023